These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1392427)

  • 1. Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients.
    Wagner D; Wagenbreth I; Stachan-Kunstyr R; Flik J
    Clin Investig; 1992 Jul; 70(7):585-7. PubMed ID: 1392427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa Gene 3 containing pre-S1, pre-S2, and S gene products.
    Wagner D; Wagenbreth I; Stachan-Kunstyr R; Thoma HA; Hemmerling AE; Flik J
    Clin Investig; 1994 May; 72(5):350-2. PubMed ID: 8086768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
    Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
    Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
    J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccination results in 140 liver transplant recipients.
    Loinaz C; de Juanes JR; Gonzalez EM; López A; Lumbreras C; Gómez R; Gonzalez-Pinto I; Jiménez C; Garcia I; Fuertes A
    Hepatogastroenterology; 1997; 44(13):235-8. PubMed ID: 9058151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The comparison of dynamics in humoral responses in health personnel after vaccination against hepatitis B using Engerix B and Gen-H-B-vax].
    Rokossowski H; Juszczyk J
    Przegl Epidemiol; 1992; 46(4):263-9. PubMed ID: 1305774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response of immunocompromised children with malignancies to a recombinant hepatitis B vaccine.
    Polychronopoulou-Androulakaki S; Panagiotou JP; Kostaridou S; Kyratzopoulou A; Haidas S
    Pediatr Hematol Oncol; 1996; 13(5):425-31. PubMed ID: 10897814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals.
    Idilman R; Colantoni A; De Maria N; Ustun C; Sam R; Ing TS; Akan H; Koc H; Van Thiel DH
    Hepatogastroenterology; 2003; 50(49):217-21. PubMed ID: 12630026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of vaccine potency against viral hepatitis B performed with HB-vax II vaccine in a group with an increased risk for hepatitis B].
    Leśnik J; Cieślak A; Krychniak E; Sitkiewicz D
    Pol Merkur Lekarski; 1996 Oct; 1(4):249-51. PubMed ID: 9156936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of hepatitis B immunoglobulin with or without hepatitis B vaccine to prevent de novo hepatitis B in pediatric recipients of anti-HBc-positive livers.
    Yamashiki N; Yoshizawa A; Ueda Y; Kaido T; Okajima H; Marusawa H; Seno H; Uemoto S
    Pediatr Transplant; 2018 Aug; 22(5):e13227. PubMed ID: 29761899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area.
    Ko WJ; Chou NK; Hsu RB; Chen YS; Wang SS; Chu SH; Lai MY
    J Heart Lung Transplant; 2001 Aug; 20(8):865-75. PubMed ID: 11502409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines.
    Coates T; Wilson R; Patrick G; André F; Watson V
    Clin Ther; 2001 Mar; 23(3):392-403. PubMed ID: 11318074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses to hepatitis B vaccination in hospital staff.
    Pead PJ
    Biomed Pharmacother; 1986; 40(7):251-3. PubMed ID: 2949784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
    Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Post-transplantation vaccination of bone-marrow transplant recipients].
    Adell C; Bayas JM; Vilella A; Perales M; Vidal J; Bertran MJ; Rojano X; Asenjo MA
    Med Clin (Barc); 2002 Oct; 119(11):405-9. PubMed ID: 12381273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation.
    Li J; Dahmen U; Dirsch OR; Gu Y; Polywka S; Fiedler M; Doebel L; Roggendorf M; Broelsch CE
    Liver Transpl; 2002 Apr; 8(4):397-404. PubMed ID: 11965586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of hepatitis B virus infection in individuals at high risk in the Cakovec Medical Center].
    Palmović D; Golubić D; Vurusić B; Petrović-Kovacić A
    Lijec Vjesn; 1993; 115(3-4):90-4. PubMed ID: 8231623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Humoral response in health service personnel after administration of hepatitis B vaccine Gen-H-B-Vax].
    Juszczyk J; Rokossowski H; Krajewska M; Piatek A
    Przegl Epidemiol; 1991; 45(1-2):11-6. PubMed ID: 1839075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination against hepatitis B in children with chronic hematologic diseases treated with immunosuppression].
    Jackowska T; Rokicka-Milewska R; Madaliński K; Kacperska E; Zupańska B; Muszyńska-Rosłan K; Kaczmarski M
    Przegl Epidemiol; 1997; 51(3):255-65. PubMed ID: 9411496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.